31 filings
10-Q
2024 Q1
KYTX
Kyverna Therapeutics Inc.
14 May 24
Quarterly report
4:29pm
8-K
KYTX
Kyverna Therapeutics Inc.
14 May 24
Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
4:25pm
10-K
2023 FY
KYTX
Kyverna Therapeutics Inc.
26 Mar 24
Annual report
4:40pm
8-K
KYTX
Kyverna Therapeutics Inc.
26 Mar 24
Kyverna Therapeutics Provides Business Update and Reports Full Year 2023 Financial Results
4:13pm
SEC STAFF
KYTX
Kyverna Therapeutics Inc.
13 Feb 24
SEC staff action: Order
12:00am
8-K
axvy7z7r
12 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:34pm
S-8
hgd93
8 Feb 24
Registration of securities for employees
4:44pm
424B4
30eiquwwqi qy491f
8 Feb 24
Prospectus supplement with pricing info
4:05pm
CERT
ec4ijqwzevyhdsgdo
8 Feb 24
Certification of approval for exchange listing
8:15am
EFFECT
ccjj4 e9fz0
8 Feb 24
Notice of effectiveness
12:15am
8-A12B
jx8yz 0d960615phlh3
5 Feb 24
Registration of securities on exchange
4:01pm
CORRESP
hih4xf5lvm8te
5 Feb 24
Correspondence with SEC
12:00am
CORRESP
b3zublo
5 Feb 24
Correspondence with SEC
12:00am
S-1/A
tf1rtixzc1i4 zp63ux
31 Jan 24
IPO registration (amended)
9:47pm
CORRESP
7se0t y1b64
25 Jan 24
Correspondence with SEC
12:00am
S-1
b2m2gn4
16 Jan 24
IPO registration
4:46pm
CORRESP
icr3x6yls
16 Jan 24
Correspondence with SEC
12:00am
UPLOAD
whfav36w
10 Jan 24
Letter from SEC
12:00am
DRS/A
07vb xo8e9qth5gd4e3
8 Jan 24
Draft registration statement (amended)
12:00am